You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

partial cystectomy

Showing 1 - 25 of 3,527
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liver Surgery Trial (laparoscopic partial cystectomy with omentoplasty)

Completed
  • Liver Surgery
  • laparoscopic partial cystectomy with omentoplasty
  • (no location specified)
Sep 5, 2022

Muscle Invasive Bladder Cancer, HER2 Expression, Radiotherapy Trial in Shanghai (Disitamab Vedotin and Toripalimab)

Recruiting
  • Muscle Invasive Bladder Cancer
  • +4 more
  • Disitamab Vedotin and Toripalimab
  • Shanghai, Shanghai, China
    Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Jul 31, 2023

Protocol for Muscle Invasive Urothelial Carcinoma of Urinary

Recruiting
  • Bladder Cancer
  • terta modal bladder preservation
  • Assiut, Assuit, Egypt
    Assuit university
Aug 13, 2022

Urinary Bladder Cancer Trial in München, Ulm, Würzburg (drug, radiation, procedure)

Active, not recruiting
  • Urinary Bladder Cancer
  • München, Germany
  • +2 more
Oct 19, 2022

Muscle Invasive Bladder Cancer, Urothelial Carcinoma Trial in Tianjin (Tislelizumab, Nab paclitaxel)

Active, not recruiting
  • Muscle Invasive Bladder Cancer
  • Urothelial Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Nov 23, 2022

Bladder Cancer, Prostate Cancer, Renal Cancer Trial in Qingdao (robot-assisted surgery)

Not yet recruiting
  • Bladder Cancer
  • +2 more
  • robot-assisted surgery
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Jul 20, 2022

Urothelial Carcinoma Trial in France (optimal TURB)

Terminated
  • Urothelial Carcinoma
  • optimal TURB
  • Aix-en-Provence, France
  • +30 more
Dec 10, 2021

Muscle Invasive Bladder Cancer Urothelial Carcinoma Trial in Tianjin (Tislelizumab Nab paclitaxel)

Recruiting
  • Muscle Invasive Bladder Cancer Urothelial Carcinoma
  • Tislelizumab Nab paclitaxel
  • Tianjin, Tianjin, China
    ianjin Medical University Second Hospital
Jun 8, 2022

Urothelial Carcinoma Bladder, PD-1 Inhibitor Trial in Shanghai (Tislelizumab, Gemcitabine, Cisplatin)

Recruiting
  • Urothelial Carcinoma Bladder
  • PD-1 Inhibitor
  • Shanghai, Shanghai, China
    Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Aug 15, 2022

Bladder Cancer Trial in Chapel Hill, Philadelphia (Pembrolizumab, Entinostat)

Recruiting
  • Bladder Cancer
  • Chapel Hill, North Carolina
  • +1 more
Oct 10, 2022

Urological Malignancies, Prostate Cancer, Renal Cell Cancer Trial in Seoul

Recruiting
  • Urological Malignancies
  • +4 more
    • Seoul, Korea, Republic of
      Yonsei Severance Hospital
    Jan 30, 2023

    Muscle Invasive Bladder Cancer Trial in Boston, Minneapolis, Salt Lake City (Nivolumab, Cisplatin, Gemcitabine)

    Completed
    Has Results
    • Muscle Invasive Bladder Cancer
    • Boston, Massachusetts
    • +2 more
    Nov 18, 2021

    Negative Surgical Margins Trial (Prostate and seminal-sparing Cystectomy, Conventional Radical Cystoprostatectomy)

    Not yet recruiting
    • Negative Surgical Margins
    • Prostate and seminal-sparing Cystectomy
    • Conventional Radical Cystoprostatectomy
    • (no location specified)
    May 30, 2023

    Urinary Bladder Cancer Trial in Guangzhou (Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin)

    Recruiting
    • Urinary Bladder Cancer
    • Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin
    • Guangzhou, Guangdong, China
      Zhujiang Hospital
    Jan 6, 2023

    Bladder Cancer Trial in United States (CG0070)

    Completed
    • Bladder Cancer
    • CG0070
    • Anchorage, Alaska
    • +16 more
    Apr 12, 2021

    Muscle Invasive Bladder Carcinoma Trial in Beijing (RC48-ADC, AK104)

    Recruiting
    • Muscle Invasive Bladder Carcinoma
    • Beijing, China
      Cancer Institute and Hospital, Chinese Academy of Medical Scienc
    Oct 6, 2023

    Urinary Bladder Cancer Trial in Assiut (cystectomy)

    Recruiting
    • Urinary Bladder Cancer
    • cystectomy
    • Assiut, أسيوط, Egypt
      Assiut university hospital
    Oct 29, 2023

    Bladder Cancer, Urothelial Carcinoma Trial in Porto Alegre (Olaparib, Durvalumab)

    Terminated
    • Bladder Cancer
    • Urothelial Carcinoma
    • Porto Alegre, Brazil
      Centro de Pesquisa em Oncologia
    Jun 14, 2021

    RARC vs LRC in A Multicenter Cohort Study

    Not yet recruiting
    • Bladder Cancer
    • Robot-assisted radical cystectomy
    • Conventional laparoscopic radical cystectomy
    • (no location specified)
    May 23, 2023

    Carcinoma, Transitional Cell Trial in San Francisco (Atezolizumab)

    Active, not recruiting
    • Carcinoma, Transitional Cell
    • San Francisco, California
      University of California, San Francisco
    May 24, 2022

    Bladder Tumor, Magnetic Resonance Imaging Trial in Guangzhou (MRI)

    Recruiting
    • Bladder Tumor
    • Magnetic Resonance Imaging
    • MRI
    • Guangzhou, Guang Dong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Sep 4, 2023

    Bladder Cancer Trial in Washington, Baltimore (Prostate capsule-sparing radical cystectomy, Nerve sparing radical cystectomy)

    Not yet recruiting
    • Bladder Cancer
    • Prostate capsule-sparing radical cystectomy
    • Nerve sparing radical cystectomy
    • Washington, District of Columbia
    • +1 more
    Mar 28, 2023

    Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma, Stage I Prostate Cancer Trial in Los Angeles (other,

    Terminated
    • Infiltrating Bladder Urothelial Carcinoma
    • +9 more
    • Cytology Specimen Collection Procedure
    • +4 more
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Nov 15, 2021

    Bladder Cancer Trial (Lymph node dissection before bladder resection, Lymph node dissection after bladder resection)

    Not yet recruiting
    • Bladder Cancer
    • Lymph node dissection before bladder resection
    • Lymph node dissection after bladder resection
    • (no location specified)
    Jul 3, 2023

    Neuroendocrine Carcinoma of the Bladder, Bladder Cancer Trial (Adebrelimab, Etoposide, Cisplatin)

    Not yet recruiting
    • Neuroendocrine Carcinoma of the Bladder
    • Bladder Cancer
    • (no location specified)
    Oct 14, 2023